SciELO - Scientific Electronic Library Online

 
vol.88 número1Impacto de un sistema de evaluación de tiempos a la reperfusión en infarto agudo de miocardio con elevación del STMaltrato en la formación médica: situación en las residencias de cardiología índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

  • Não possue artigos citadosCitado por SciELO

Links relacionados

  • Não possue artigos similaresSimilares em SciELO

Compartilhar


Revista argentina de cardiología

versão On-line ISSN 1850-3748

Resumo

MASSON, WALTER et al. Lipid Goals in Diabetic Patients. Clinical Implications after Application of a New Formula for LDL-cholesterol Calculation. Rev. argent. cardiol. [online]. 2020, vol.88, n.1, pp.41-47.  Epub 01-Fev-2020. ISSN 1850-3748.  http://dx.doi.org/10.7775/rac.es.v88.i1.16342.

Background:

There are clear recommendations for lipid management in diabetic patients. A new formula for the calculation of LDL-cholesterol (LDL-C) would improve the inaccuracy of the Friedewald formula.

Objectives:

The aim of this study was to analyze the use of statins and the fulfillment of lipid goals in diabetic patients, evaluating the consequences of applying a new formula for LDL-C calculation.

Methods:

This was a descriptive, cross-sectional, multicenter study including type 2 diabetic patients over 18 years of age. LDL-C was calculated using the classic Friedewald formula and the new formula. Recommendations of the position document for the appropriate use of statins from the Argentine Society of Cardiology were followed.

Results:

A total of 528 patients were included in the study. In secondary prevention, 77.2% of patients received statins (23.4% high-intensity statins) and 36.6% and 36.0% of these patients achieved the goals of LDL-C below 70% mg/dl and non-HDL-C below 100 mg/dl, respectively. In 20.8% of patients with LDL-C below 70 mg/dl according to the Friedewald formula, this goal was not attained when the new formula was applied. In primary prevention, 62.2% patients with risk factors or white organ damage received statins (14.7% high-intensity statins) and 20.9% and 20.4% achieved the goals of LDL-C below 70% mg/dl and non-HDL-C below 100 mg/dl. In 27.7% of patients with LDL-C below 70 mg/dl using the Friedewald formula, this goal was not reached when applying the new formula. More patients did not achieve the LDL-C goal with the new formula when the triglyceride level was higher.

Conclusion:

In this population, the appropriate use of statins and the fulfillment of lipid goals were poor. Applying the new LDL-C formula optimized the evaluation of these patients.

Palavras-chave : Diabetes Mellitus, Type 2; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Goals Models, Theoretical; Cholesterol, LDL.

        · resumo em Espanhol     · texto em Espanhol     · Inglês ( pdf ) | Espanhol ( pdf )